2026 Q2 -tulosraportti
UUTTA
6 päivää sitten
‧48 min
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 28.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 29.7. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 18.2. | ||
2025 Q3 -tulosraportti 29.10.2025 | ||
2025 Q2 -tulosraportti 30.7.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·12 min sittenCompletely independent of the outcome, Pho will have to spend "some" tens of millions in legal fees. That is money lost. But as such, it just fits into the endless series of exactly that. Lost money. Business as usual for Pho. Fortunately, they have just enough income to cover salary, commission, remuneration and other fees for the "irreplaceable" management. At least almost enough. Occasionally they have to supplement with some payments from their shareholders, who willingly step up, every single time.
·2 t sittenThis unfortunately shows the challenge with Pho. They generally struggle with business matters. To me, it looks like management is mostly focused on their own gain. They fail to create proper growth, and time and again we see that the business side is not in place. If they have a focus beyond this, I suspect it's "better medicine" instead of "profit for the shareholders". What Pho needs more than anything else is a management with commercial international experience. The agreement currently being discussed is not the responsibility of the current management, but the challenges nevertheless become clear in the stock exchange announcement. The information provided is in principle only that they disagree, not about what and how Pho views it. In other words, they do not provide investors with sufficient information to make their own assessments. This causes the stock to be priced lower than it could have been, and it has been like this for years. If no more information comes, I guess we will go down towards the previous low of 40. At the same time, I fear that this time we will go even lower, as the belief that Pho will achieve profitability in China is in the process of disappearing. Many probably think that China will be a new "USA adventure" for Pho. As others here have said, what is different from when Pho was in the 20s? The answer is China, so if China doesn't deliver... For the record, I have owned Pho many times, and will surely own Pho again. Last time I bought around 43 and sold a little over 60 if I remember correctly.
How should pho NOT make money in kina? They surely have no expenses there, just royalties from sales?- ·3 t sittenGood post from Rosk82 on tekinvestor: "But I don't see how Asieris will be able to argue this in a potential case. AAA is known for only looking at what is written in the contracts. What is written in black and white, and how to interpret this purely legally. When you then have a party that then: Announces to the market that approval is in the bag. Announces first patient treated. Then says that they are withholding 40% based on their own interpretation. Announces to shareholders that they are satisfied with the product, everything is going smoothly and only disagreement on the milestone itself. Then files a counterclaim and claims NO milestones have been reached, after they have been reported to AAA. After the product has been on the market for almost 2 months… We know that the product is approved. We know it is being sold as of today. Difficult not to have triggered a milestone if the product is sold, at the same time as Asieris itself has acknowledged partial payment due to approved CIN2 treatment. Just there we know that Asieris' argument is "dead on arrival". That Asieris now comes with a counterclaim to force a negotiation based on the above facts, perhaps says more about how uncertain their argument initially was for withholding 40%??"
Asieris is probably trying a questionable method to get the remaining 4.4mill NOK reduced. Nonsense! 
·3 t sittenReally a bad climate for a future collaboration. What will be next ?? Will Photocure demand prepayment just to get their royalty.. This is absolutely crazy !! The Chinese are just screwing over the hopeless amateurs at Photocure.
The dispute is not about whether it is approved, but for whom it is approved. Who is right depends on what is stated in the agreement and how it can be interpreted legally. It is not clear who is right here. The license holder knows the intention of the agreement best, but whether that is what is actually stated and whether it is obvious that Asieris should interpret it that way is not as clear. Another element is whether PHO has the right to withdraw the license or demand a stop to its use in case of a dispute. In that case, it could function as an effective means of pressure.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
UUTTA
6 päivää sitten
‧48 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·12 min sittenCompletely independent of the outcome, Pho will have to spend "some" tens of millions in legal fees. That is money lost. But as such, it just fits into the endless series of exactly that. Lost money. Business as usual for Pho. Fortunately, they have just enough income to cover salary, commission, remuneration and other fees for the "irreplaceable" management. At least almost enough. Occasionally they have to supplement with some payments from their shareholders, who willingly step up, every single time.
- ·2 t sittenThis unfortunately shows the challenge with Pho. They generally struggle with business matters. To me, it looks like management is mostly focused on their own gain. They fail to create proper growth, and time and again we see that the business side is not in place. If they have a focus beyond this, I suspect it's "better medicine" instead of "profit for the shareholders". What Pho needs more than anything else is a management with commercial international experience. The agreement currently being discussed is not the responsibility of the current management, but the challenges nevertheless become clear in the stock exchange announcement. The information provided is in principle only that they disagree, not about what and how Pho views it. In other words, they do not provide investors with sufficient information to make their own assessments. This causes the stock to be priced lower than it could have been, and it has been like this for years. If no more information comes, I guess we will go down towards the previous low of 40. At the same time, I fear that this time we will go even lower, as the belief that Pho will achieve profitability in China is in the process of disappearing. Many probably think that China will be a new "USA adventure" for Pho. As others here have said, what is different from when Pho was in the 20s? The answer is China, so if China doesn't deliver... For the record, I have owned Pho many times, and will surely own Pho again. Last time I bought around 43 and sold a little over 60 if I remember correctly.How should pho NOT make money in kina? They surely have no expenses there, just royalties from sales?
- ·3 t sittenGood post from Rosk82 on tekinvestor: "But I don't see how Asieris will be able to argue this in a potential case. AAA is known for only looking at what is written in the contracts. What is written in black and white, and how to interpret this purely legally. When you then have a party that then: Announces to the market that approval is in the bag. Announces first patient treated. Then says that they are withholding 40% based on their own interpretation. Announces to shareholders that they are satisfied with the product, everything is going smoothly and only disagreement on the milestone itself. Then files a counterclaim and claims NO milestones have been reached, after they have been reported to AAA. After the product has been on the market for almost 2 months… We know that the product is approved. We know it is being sold as of today. Difficult not to have triggered a milestone if the product is sold, at the same time as Asieris itself has acknowledged partial payment due to approved CIN2 treatment. Just there we know that Asieris' argument is "dead on arrival". That Asieris now comes with a counterclaim to force a negotiation based on the above facts, perhaps says more about how uncertain their argument initially was for withholding 40%??"Asieris is probably trying a questionable method to get the remaining 4.4mill NOK reduced. Nonsense!
- ·3 t sittenReally a bad climate for a future collaboration. What will be next ?? Will Photocure demand prepayment just to get their royalty.. This is absolutely crazy !! The Chinese are just screwing over the hopeless amateurs at Photocure.The dispute is not about whether it is approved, but for whom it is approved. Who is right depends on what is stated in the agreement and how it can be interpreted legally. It is not clear who is right here. The license holder knows the intention of the agreement best, but whether that is what is actually stated and whether it is obvious that Asieris should interpret it that way is not as clear. Another element is whether PHO has the right to withdraw the license or demand a stop to its use in case of a dispute. In that case, it could function as an effective means of pressure.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 28.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 29.7. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 18.2. | ||
2025 Q3 -tulosraportti 29.10.2025 | ||
2025 Q2 -tulosraportti 30.7.2025 |
2026 Q2 -tulosraportti
UUTTA
6 päivää sitten
‧48 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 28.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 29.7. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 18.2. | ||
2025 Q3 -tulosraportti 29.10.2025 | ||
2025 Q2 -tulosraportti 30.7.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·12 min sittenCompletely independent of the outcome, Pho will have to spend "some" tens of millions in legal fees. That is money lost. But as such, it just fits into the endless series of exactly that. Lost money. Business as usual for Pho. Fortunately, they have just enough income to cover salary, commission, remuneration and other fees for the "irreplaceable" management. At least almost enough. Occasionally they have to supplement with some payments from their shareholders, who willingly step up, every single time.
- ·2 t sittenThis unfortunately shows the challenge with Pho. They generally struggle with business matters. To me, it looks like management is mostly focused on their own gain. They fail to create proper growth, and time and again we see that the business side is not in place. If they have a focus beyond this, I suspect it's "better medicine" instead of "profit for the shareholders". What Pho needs more than anything else is a management with commercial international experience. The agreement currently being discussed is not the responsibility of the current management, but the challenges nevertheless become clear in the stock exchange announcement. The information provided is in principle only that they disagree, not about what and how Pho views it. In other words, they do not provide investors with sufficient information to make their own assessments. This causes the stock to be priced lower than it could have been, and it has been like this for years. If no more information comes, I guess we will go down towards the previous low of 40. At the same time, I fear that this time we will go even lower, as the belief that Pho will achieve profitability in China is in the process of disappearing. Many probably think that China will be a new "USA adventure" for Pho. As others here have said, what is different from when Pho was in the 20s? The answer is China, so if China doesn't deliver... For the record, I have owned Pho many times, and will surely own Pho again. Last time I bought around 43 and sold a little over 60 if I remember correctly.How should pho NOT make money in kina? They surely have no expenses there, just royalties from sales?
- ·3 t sittenGood post from Rosk82 on tekinvestor: "But I don't see how Asieris will be able to argue this in a potential case. AAA is known for only looking at what is written in the contracts. What is written in black and white, and how to interpret this purely legally. When you then have a party that then: Announces to the market that approval is in the bag. Announces first patient treated. Then says that they are withholding 40% based on their own interpretation. Announces to shareholders that they are satisfied with the product, everything is going smoothly and only disagreement on the milestone itself. Then files a counterclaim and claims NO milestones have been reached, after they have been reported to AAA. After the product has been on the market for almost 2 months… We know that the product is approved. We know it is being sold as of today. Difficult not to have triggered a milestone if the product is sold, at the same time as Asieris itself has acknowledged partial payment due to approved CIN2 treatment. Just there we know that Asieris' argument is "dead on arrival". That Asieris now comes with a counterclaim to force a negotiation based on the above facts, perhaps says more about how uncertain their argument initially was for withholding 40%??"Asieris is probably trying a questionable method to get the remaining 4.4mill NOK reduced. Nonsense!
- ·3 t sittenReally a bad climate for a future collaboration. What will be next ?? Will Photocure demand prepayment just to get their royalty.. This is absolutely crazy !! The Chinese are just screwing over the hopeless amateurs at Photocure.The dispute is not about whether it is approved, but for whom it is approved. Who is right depends on what is stated in the agreement and how it can be interpreted legally. It is not clear who is right here. The license holder knows the intention of the agreement best, but whether that is what is actually stated and whether it is obvious that Asieris should interpret it that way is not as clear. Another element is whether PHO has the right to withdraw the license or demand a stop to its use in case of a dispute. In that case, it could function as an effective means of pressure.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt